Literature DB >> 22707062

Functional polymorphisms in the P2X7 receptor gene are associated with osteoporosis.

L B Husted1, T Harsløf, L Stenkjær, M Carstens, N R Jørgensen, B L Langdahl.   

Abstract

UNLABELLED: The P2X(7) receptor is an ATP-gated cation channel. We investigated the effect of both loss-of-function and gain-of-function polymorphisms in the P2X(7) receptor gene on BMD and risk of vertebral fractures and found that five polymorphisms and haplotypes containing three of these polymorphisms were associated with BMD and fracture risk.
INTRODUCTION: The P2X(7) receptor is an ATP-gated cation channel. P2X(7) receptor knockout mice have reduced total bone mineral content, and because several functional polymorphisms have been identified in the human P2X(7) receptor gene, we wanted to investigate the effect of these polymorphisms on BMD and risk of vertebral fractures in a case-control study including 798 individuals.
METHODS: Genotyping was carried out using TaqMan assays. BMD was measured using dual energy X-ray absorptiometry, and vertebral fractures were assessed by lateral spinal X-rays.
RESULTS: The rare allele of a splice site polymorphism, 151 + 1: G-T, was associated with increased fracture risk and reduced BMD in women. Two other loss-of-function polymorphisms, Glu496Ala and Gly150Arg, were also associated with BMD. The Glu496Ala variant allele was associated with decreased lumbar spine BMD in women and decreased total hip BMD in men. The 150Arg allele was associated with decreased total hip BMD in women and men combined. The minor allele of the gain-of-function polymorphism, Ala348Thr, was associated with reduced fracture risk and increased BMD at all sites in men. The Gln460Arg variant allele, which has been associated with increased receptor function in monocytes, was associated with increased total hip BMD in women. With the exception of His155Tyr for which we found conflicting results in men and women, our results are consistent with the phenotype of the knockout mouse. Analysis of a haplotype containing Ala348Thr, Gln460Arg, and Glu496Ala showed that the effects of the haplotypes on BMD and fracture were driven by Ala348Thr in men and by Gln460Arg and Glu496Ala in women.
CONCLUSION: In conclusion, we found that functional polymorphisms in the P2X(7) receptor gene and haplotypes containing three of these polymorphisms are associated with osteoporosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22707062     DOI: 10.1007/s00198-012-2035-5

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  50 in total

1.  Intercellular calcium signaling occurs between human osteoblasts and osteoclasts and requires activation of osteoclast P2X7 receptors.

Authors:  Niklas R Jørgensen; Zanne Henriksen; Ole H Sørensen; Erik F Eriksen; Roberto Civitelli; Thomas H Steinberg
Journal:  J Biol Chem       Date:  2001-12-27       Impact factor: 5.157

2.  A genome-wide association study of global gene expression.

Authors:  Anna L Dixon; Liming Liang; Miriam F Moffatt; Wei Chen; Simon Heath; Kenny C C Wong; Jenny Taylor; Edward Burnett; Ivo Gut; Martin Farrall; G Mark Lathrop; Gonçalo R Abecasis; William O C Cookson
Journal:  Nat Genet       Date:  2007-09-16       Impact factor: 38.330

Review 3.  Nucleotide receptors: an emerging family of regulatory molecules in blood cells.

Authors:  F Di Virgilio; P Chiozzi; D Ferrari; S Falzoni; J M Sanz; A Morelli; M Torboli; G Bolognesi; O R Baricordi
Journal:  Blood       Date:  2001-02-01       Impact factor: 22.113

Review 4.  P2X receptors as cell-surface ATP sensors in health and disease.

Authors:  Baljit S Khakh; R Alan North
Journal:  Nature       Date:  2006-08-03       Impact factor: 49.962

5.  A 5' intronic splice site polymorphism leads to a null allele of the P2X7 gene in 1-2% of the Caucasian population.

Authors:  Kristen K Skarratt; Stephen J Fuller; Ronald Sluyter; Lan-Phuong Dao-Ung; Ben J Gu; James S Wiley
Journal:  FEBS Lett       Date:  2005-04-14       Impact factor: 4.124

6.  A Thr357 to Ser polymorphism in homozygous and compound heterozygous subjects causes absent or reduced P2X7 function and impairs ATP-induced mycobacterial killing by macrophages.

Authors:  Anne N Shemon; Ronald Sluyter; Suran L Fernando; Alison L Clarke; Lan-Phuong Dao-Ung; Kristen K Skarratt; Bernadette M Saunders; Khai See Tan; Ben J Gu; Stephen J Fuller; Warwick J Britton; Steven Petrou; James S Wiley
Journal:  J Biol Chem       Date:  2005-11-01       Impact factor: 5.157

7.  Expression of a P2X7 receptor by a subpopulation of human osteoblasts.

Authors:  A Gartland; R A Hipskind; J A Gallagher; W B Bowler
Journal:  J Bone Miner Res       Date:  2001-05       Impact factor: 6.741

8.  Expression of P2 receptors in bone and cultured bone cells.

Authors:  A Hoebertz; A Townsend-Nicholson; R Glass; G Burnstock; T R Arnett
Journal:  Bone       Date:  2000-10       Impact factor: 4.398

9.  Human P2X7 pore function predicts allele linkage disequilibrium.

Authors:  Loren C Denlinger; Douglas B Coursin; Kathleen Schell; Giuditta Angelini; Dawn N Green; Arturo G Guadarrama; Jennifer Halsey; Usha Prabhu; Kirk J Hogan; Paul J Bertics
Journal:  Clin Chem       Date:  2006-04-13       Impact factor: 8.327

10.  An Arg307 to Gln polymorphism within the ATP-binding site causes loss of function of the human P2X7 receptor.

Authors:  Ben J Gu; Ronald Sluyter; Kristen K Skarratt; Anne N Shemon; Lan-Phuong Dao-Ung; Stephen J Fuller; Julian A Barden; Alison L Clarke; Steven Petrou; James S Wiley
Journal:  J Biol Chem       Date:  2004-04-27       Impact factor: 5.157

View more
  15 in total

Review 1.  Purinergic signalling in the musculoskeletal system.

Authors:  Geoffrey Burnstock; Timothy R Arnett; Isabel R Orriss
Journal:  Purinergic Signal       Date:  2013-08-14       Impact factor: 3.765

Review 2.  Purinergic Signalling: Therapeutic Developments.

Authors:  Geoffrey Burnstock
Journal:  Front Pharmacol       Date:  2017-09-25       Impact factor: 5.810

3.  Purinergic P2X7 receptor functional genetic polymorphisms are associated with the susceptibility to osteoporosis in Chinese postmenopausal women.

Authors:  Hong Xu; Chengxin Gong; Luling He; Shenqiang Rao; Xingzi Liu; Yijun Nie; Changle Liu; Tao Li; Lu Ding; Yunming Tu; Yuping Yang; Fangfang Hu; Yongfang Fan; Hui Wang; Shuo Wang; Chaopeng Xiong; Peipei Zhong; Lan Tang; Shangdong Liang
Journal:  Purinergic Signal       Date:  2017-05-11       Impact factor: 3.765

4.  Genetic interaction of purinergic P2X7 receptor and ER-α polymorphisms in susceptibility to osteoporosis in Chinese postmenopausal women.

Authors:  Hui Wang; Chengxin Gong; Xingzi Liu; Shenqiang Rao; Tao Li; Luling He; Yijun Nie; Shuo Wang; Peipei Zhong; Yansong Xue; Jihong Wang; Jiani Zhao; Yuru Zhou; Lu Ding; Yunming Tu; Yuping Yang; Chaopeng Xiong; Shangdong Liang; Hong Xu
Journal:  J Bone Miner Metab       Date:  2017-09-07       Impact factor: 2.626

5.  Non-synonymous polymorphisms in the P2RX ( 4 ) are related to bone mineral density and osteoporosis risk in a cohort of Dutch fracture patients.

Authors:  Anke Wesselius; Martijn Jl Bours; Niklas R Jørgensen; James Wiley; Ben Gu; Svenjhalmar van Helden; Lodewijk van Rhijn; Pieter C Dagnelie
Journal:  Purinergic Signal       Date:  2012-11-10       Impact factor: 3.765

6.  Functional polymorphisms in the P2X7 receptor gene are associated with stress fracture injury.

Authors:  Ian Varley; Julie P Greeves; Craig Sale; Eitan Friedman; Daniel S Moran; Ran Yanovich; Peter J Wilson; Alison Gartland; David C Hughes; Trent Stellingwerff; Craig Ranson; William D Fraser; James A Gallagher
Journal:  Purinergic Signal       Date:  2016-01-29       Impact factor: 3.765

7.  Bone phenotype of P2X4 receptor knockout mice: implication of a P2X7 receptor mutation?

Authors:  Maria Ellegaard; Tanja Hegner; Ming Ding; Lauriane Ulmann; Niklas Rye Jørgensen
Journal:  Purinergic Signal       Date:  2021-04-15       Impact factor: 3.765

Review 8.  P2X7Rs: new therapeutic targets for osteoporosis.

Authors:  Haoyun Huang; Yu-Mei He; Miao-Miao Lin; Yanchao Wang; Xiaomei Zhang; Li Liang; Xueling He
Journal:  Purinergic Signal       Date:  2022-02-02       Impact factor: 3.765

9.  Association of P2X7 receptor polymorphisms with bone mineral density and osteoporosis risk in a cohort of Dutch fracture patients.

Authors:  A Wesselius; M J L Bours; Z Henriksen; S Syberg; S Petersen; P Schwarz; N R Jørgensen; S van Helden; P C Dagnelie
Journal:  Osteoporos Int       Date:  2012-07-10       Impact factor: 4.507

10.  Insights into the Molecular Mechanisms Underlying Mammalian P2X7 Receptor Functions and Contributions in Diseases, Revealed by Structural Modeling and Single Nucleotide Polymorphisms.

Authors:  Lin-Hua Jiang; Jocelyn M Baldwin; Sebastien Roger; Stephen A Baldwin
Journal:  Front Pharmacol       Date:  2013-05-07       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.